Cancer-related gene regulation
Cancer-related gene regulation is a research topic within Molecular Biology. Science Explorer counts 36k research works in it since 1950. 22.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the role of protein arginine methylation, particularly by PRMT1 and PRMT5, in mammals. It explores its involvement in histone methylation, transcriptional regulation, epigenetic control, and its implications in cancer and cell proliferation.
- Arginine Methylation
- Protein Arginine Methyltransferases
- Histone Methylation
- PRMT5
- Cancer
- Transcriptional Regulation
- PRMT1
- Epigenetic Regulation
- Methylation Sites
- Cell Proliferation
- Research works
- 36k fractional, since 1950
- In the world top 10%
- 7.9k per year above
- Top-10% rate
- 22.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +9% the tick is no change
Which countries lead Cancer-related gene regulation research?
By volume, China and the United States publish the most (2.8k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.8k works
- 2 United States 1.1k works
- 3 Japan 208 works
- 4 India 184 works
- 5 Germany 178 works
- 6 United Kingdom 129 works
- 7 South Korea 118 works
- 8 Canada 98 works
- 9 France 98 works
- 10 Italy 97 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer-related gene regulation research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Cancer-related gene regulation research, followed by Central South University and Nanjing Medical University.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 49 works
- 2 Central South UniversityChina 41 works
- 3 Nanjing Medical UniversityChina 35 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 34 works
- 5 Sichuan UniversityChina 32 works
- 6 Shanghai Jiao Tong UniversityChina 29 works
- 7 China Medical UniversityChina 29 works
- 8 First Affiliated Hospital of Zhengzhou UniversityChina 27 works
- 9 Zhejiang UniversityChina 26 works
- 10 University of North Carolina at Chapel HillUnited States 25 works
Who are the leading researchers in Cancer-related gene regulation?
The most-cited researchers publishing on Cancer-related gene regulation include Andrew P. Feinberg.
- 1 Andrew P. Feinberg United States 4.5k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cancer-related gene regulation research done?
The largest centres of Cancer-related gene regulation research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nantong.
Largest cities, 2022–2025
Where it is the local speciality
- NantongCN · 26.1 works10×
Location quotient: how much more of its research is in Cancer-related gene regulation than the world average.
Where is the best place to study Cancer-related gene regulation?
Among universities, judged by research, Sun Yat-sen University, Guangzhou Medical University and China Pharmaceutical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Sun Yat-sen UniversityChina | 64.0 | 36.7% | 5.6× | 49 | +57.4% |
| 2 | Guangzhou Medical UniversityChina | 63.5 | 28.2% | 13.3× | 20 | +124.4% |
| 3 | China Pharmaceutical UniversityChina | 59.6 | 35.5% | 9.7× | 12 | +97.6% |
| 4 | Nanjing Medical UniversityChina | 59.1 | 25.2% | 12.4× | 35 | -1.9% |
| 5 | China Medical UniversityChina | 58.1 | 29.3% | 16.4× | 29 | -34.0% |
| 6 | Harbin Medical UniversityChina | 54.1 | 25.8% | 16.3× | 18 | +28.9% |
| 7 | Southern Medical UniversityChina | 53.5 | 27.6% | 9.3× | 18 | +18.5% |
| 8 | Zhejiang UniversityChina | 51.2 | 28.8% | 2.3× | 26 | +199.9% |
| 9 | Shandong First Medical UniversityChina | 49.1 | 19.4% | 12.1× | 17 | +33.2% |
| 10 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 48.8 | 24.8% | 6.3× | 34 | -8.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cancer-related gene regulation research growing?
Output in 2018–2022 was 9% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Cancer-related gene regulation.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.